Fusion Pharmaceuticals Statistics
Total Valuation
FUSN has a market cap or net worth of $1.83 billion. The enterprise value is $1.68 billion.
| Market Cap | 1.83B |
| Enterprise Value | 1.68B |
Important Dates
The last earnings date was Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
FUSN has 85.06 million shares outstanding. The number of shares has increased by 55.79% in one year.
| Shares Outstanding | 85.06M |
| Shares Change (YoY) | +55.79% |
| Shares Change (QoQ) | +14.48% |
| Owned by Insiders (%) | 0.47% |
| Owned by Institutions (%) | 86.34% |
| Float | 63.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 896.26 |
| Forward PS | n/a |
| PB Ratio | 7.56 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 824.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.64, with a Debt / Equity ratio of 0.27.
| Current Ratio | 10.64 |
| Quick Ratio | n/a |
| Debt / Equity | 0.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.90 |
Financial Efficiency
Return on equity (ROE) is -48.70% and return on invested capital (ROIC) is -35.98%.
| Return on Equity (ROE) | -48.70% |
| Return on Assets (ROA) | -36.90% |
| Return on Capital (ROIC) | -35.98% |
| Revenue Per Employee | $20,198 |
| Profits Per Employee | -$1.03M |
| Employee Count | 101 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, FUSN has paid $561,000 in taxes.
| Income Tax | 561,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +392.22% in the last 52 weeks. The beta is -0.72, so FUSN's price volatility has been lower than the market average.
| Beta (1Y) | -0.72 |
| 52-Week Price Change | +392.22% |
| 50-Day Moving Average | 19.73 |
| 200-Day Moving Average | 9.50 |
| Relative Strength Index (RSI) | 72.79 |
| Average Volume (30 Days) | 1,946,561 |
Short Selling Information
The latest short interest is 3.95 million, so 4.64% of the outstanding shares have been sold short.
| Short Interest | 3.95M |
| Short Previous Month | 4.86M |
| Short % of Shares Out | 4.64% |
| Short % of Float | 6.22% |
| Short Ratio (days to cover) | 3.65 |
Income Statement
In the last 12 months, FUSN had revenue of $2.04 million and -$104.28 million in losses. Loss per share was -$1.42.
| Revenue | 2.04M |
| Gross Profit | 2.04M |
| Operating Income | -110.24M |
| Pretax Income | -103.72M |
| Net Income | -104.28M |
| EBITDA | -93.51M |
| EBIT | -97.92M |
| Loss Per Share | -$1.42 |
Balance Sheet
The company has $211.84 million in cash and $64.55 million in debt, giving a net cash position of $147.30 million or $1.73 per share.
| Cash & Cash Equivalents | 211.84M |
| Total Debt | 64.55M |
| Net Cash | 147.30M |
| Net Cash Per Share | $1.73 |
| Equity / Book Value | 241.83M |
| Book Value Per Share | 2.84 |
| Working Capital | 200.16M |
Cash Flow
In the last 12 months, operating cash flow was -$83.67 million and capital expenditures -$4.00 million, giving a free cash flow of -$87.67 million.
| Operating Cash Flow | -83.67M |
| Capital Expenditures | -4.00M |
| Free Cash Flow | -87.67M |
| FCF Per Share | -$1.05 |
Margins
Gross margin is 100.00%, with operating and profit margins of -5,403.77% and -5,111.57%.
| Gross Margin | 100.00% |
| Operating Margin | -5,403.77% |
| Pretax Margin | -5,084.07% |
| Profit Margin | -5,111.57% |
| EBITDA Margin | -4,584.02% |
| EBIT Margin | -4,800.00% |
| FCF Margin | -4,297.75% |
Dividends & Yields
FUSN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -55.79% |
| Shareholder Yield | -55.79% |
| Earnings Yield | -5.70% |
| FCF Yield | -4.80% |
Analyst Forecast
The average price target for FUSN is $20.86, which is -3.02% lower than the current price. The consensus rating is "Hold".
| Price Target | $20.86 |
| Price Target Difference | -3.02% |
| Analyst Consensus | Hold |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 89.86% |
| EPS Growth Forecast (5Y) | -5.83% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FUSN has an Altman Z-Score of 11.36 and a Piotroski F-Score of 2.
| Altman Z-Score | 11.36 |
| Piotroski F-Score | 2 |